Skip to main content

Spectrum: Autism Research News

Molecular mechanisms: Deletion moves inhibitory neurons

by  /  1 March 2013
THIS ARTICLE IS MORE THAN FIVE YEARS OLD

This article is more than five years old. Autism research — and science in general — is constantly evolving, so older articles may contain information or theories that have been reevaluated since their original publication date.

Lost cells: An autism-linked deletion (middle) and a single-gene mutation (top) both alter the location of neurons (green) in the brain (into the ventricular zone, or VZ, layer). Combining the mutations exacerbates the effect (bottom).

Loss of one copy of 22q11.2 — a chromosomal region linked to schizophrenia and autism — shifts the location of neurons that inhibit brain signals, according to a study published 6 November in Proceedings of the National Academy of Sciences1.

The deletion also results in abnormally low levels of CXCR4, a protein involved in neuronal development and migration through the brain.

Postmortem brains from people with a deletion in 22q11.2 have misplaced neurons in the cerebral cortex, a brain region needed for most higher-order functions2. They also have deficits in inhibitory neurons that release the chemical messenger gamma-aminobutyric acid (GABA). Several studies have linked defects in GABA and inhibitory neurons to autism.

In the new study, researchers looked at fluorescently labeled neurons in mice lacking one copy of the 22q11.2 region. These mice harbor parvalbumin neurons, one type of inhibitory neuron, in superficial brain regions, compared with deeper regions in controls.

These neurons also move differently than in controls and take an altered route through the developing brains of mutant mice, the study found.

The mutant mice also have 35 percent less CXCR4 than controls do. CXCR4 guides inhibitory neurons to their proper locations during development. Mice lacking one copy of this gene in parvalbumin neurons show the same abnormal neuron placement. Combining both mutations worsens the effect.

This suggests that the 22q11.2 deletion affects the brain partly through CXCR4, making it a candidate risk gene for schizophrenia and autism, the researchers say. 

References:

1:Meechan D.W. et al. Proc. Natl. Acad. Sci. USA 109, 18601-18606 (2012) PubMed

2:Kiehl T.R. et al. Cereb. Cortex 19, 153-164 (2009) PubMed